Login / Signup

rMELEISH: A Novel Recombinant Multiepitope-Based Protein Applied to the Serodiagnosis of Both Canine and Human Visceral Leishmaniasis.

Daniel Silva DiasJuliana Martins MachadoPatrícia Aparecida Fernandes RibeiroAmanda Sanchez MachadoFernanda Fonseca RamosLais Moreira NogueiraAna Alice Maia GonçalvesLuana de Sousa RamosIsadora Braga GandraFlaviane Silva CoutinhoMichelli Dos SantosJonatas Oliveira da SilvaMiguel Angel Chávez-FumagalliRafael Gonçalves Teixeira-NetoAna Thereza ChavesMariana Campos-da-PazAmanda A SouzaRodolfo Cordeiro GiunchettiSonia Maria de FreitasSandra LyonDanielle Ferreira de Magalhães-SoaresJulia Angelica Gonçalves SilveiraEduardo Sergio SilvaEduardo Antônio Ferraz CoelhoAlexsandro Sobreira Galdino
Published in: Pathogens (Basel, Switzerland) (2023)
the preliminary data suggest that rMELEISH has the potential to be tested in future studies against a larger serological panel and in field conditions for the diagnosis of canine and human VL.
Keyphrases
  • endothelial cells
  • induced pluripotent stem cells
  • pluripotent stem cells
  • machine learning
  • risk assessment
  • big data
  • small molecule
  • current status
  • cell free
  • case control
  • deep learning
  • artificial intelligence